Longwood Fund
Overview
Longwood creates and invests in science-based companies that develop novel solutions for important medical problems
Investment Focus
- Focus on biotechnology and healthcare sectors
- Target companies at various stages, including seed, early stage, growth, and late stage
- Commitment to advancing new therapeutics that improve patients' lives
- Innovative healthcare solutions
- Experienced management teams
- Strong scientific foundation
- Scalable business models
- Potential for significant patient impact
Portfolio Companies
Reach Longwood Fund directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Longwood Fund
What sectors does Longwood Fund invest in?
Longwood Fund invests in Healthcare, Life Sciences, Digital Health, Pharmaceuticals, Medical Devices and Diagnostics, and is based in Boston, Massachusetts, United States. Longwood Fund is listed as a vc in the ConnectSafely investor database.
What stage does Longwood Fund invest at?
Longwood Fund backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Longwood Fund invest in?
Longwood Fund invests across United States.
Who are the partners at Longwood Fund?
Team members listed for Longwood Fund include Roger Tung (Venture Partner) and John McCabe (Operating Partner).
What companies has Longwood Fund invested in?
Longwood Fund's portfolio includes Acceleron Pharma, Pyxis Oncology, Kronos Bio, Alnylam Pharmaceuticals, Vertex Pharmaceuticals, Kura Oncology, Mersana Therapeutics and Aptinyx.
How do I contact Longwood Fund?
Longwood Fund's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
